Breast Cancer Research and Treatment

, Volume 129, Issue 2, pp 309–317

Pregnancy after breast cancer: if you wish, ma’am

  • Olivia Pagani
  • Ann Partridge
  • Larissa Korde
  • Sunil Badve
  • John Bartlett
  • Kathy Albain
  • Richard Gelber
  • Aron Goldhirsch


A growing number of young breast cancer survivors consider reproductive health issues, including subsequent fertility and pregnancy, of great importance, but many questions regarding safety remain unanswered. We conducted a comprehensive literature search and review of published articles, control-matched, population-based, and co-operative group reports that addressed various aspects of pregnancy after breast cancer (patients’ expectations, fertility damage, assessment and preservation, maternal and fetal outcome, breast feeding). Overall, available data support pregnancy and breast feeding after breast cancer as safe and feasible for women at low risk of recurrence. This retrospective and population-based evidence is, however, frequently incomplete; usually not representative of the entire population, it can be biased by patients’ related effects or underpowered and is often not controlled for biological factors and risk determinants in the statistical model used. Before making any definitive assumption on this delicate and fundamental aspect of a woman’s life after breast cancer, we should demonstrate without any reasonable doubt that the scattered information available today is scientifically sound. The Breast International Group and North American Breast Cancer Group are planning a global prospective study in young women with endocrine responsive, early breast cancer who desire pregnancy, to assess both patients’ and pregnancy outcomes. The trial will include an observational phase investigating the feasibility and impact of a temporary treatment interruption to allow conception and an experimental phase investigating the optimal duration of the subsequent endocrine treatment after delivery or the last failed attempt to get pregnant.


Breast cancer Pregnancy Fertility Breast feeding 


  1. 1.
    Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643–1648PubMedCrossRefGoogle Scholar
  2. 2.
    Goldhirsch A, Gelber RD (2004) Breast cancer in young women. In: Harris JR, Lippman ME, Morrow M et al (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, MD, pp 1339–1349Google Scholar
  3. 3.
    Kroman N, Jensen MB, Wohlfahrt J et al (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478PubMedCrossRefGoogle Scholar
  4. 4.
    Aebi S, Castiglione M (2006) The enigma of young age. Ann Oncol 17(10):1475–1477PubMedCrossRefGoogle Scholar
  5. 5.
    Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330PubMedCrossRefGoogle Scholar
  6. 6.
    Sant M, Allemani C, Berrino F (2004) European concerted action on survival and care of cancer patients (EUROCARE) working group. Breast carcinoma survival in Europe and the United States. Cancer 100(4):715–722PubMedCrossRefGoogle Scholar
  7. 7.
    Cancello G, Maisonneuve P, Rotmensz N et al (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 21(10):1974–1981PubMedCrossRefGoogle Scholar
  8. 8.
    Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183PubMedCrossRefGoogle Scholar
  9. 9.
    Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673–1684PubMedCrossRefGoogle Scholar
  10. 10.
    Smith I, Procter M, Gelber RD et al (2007) 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369(9555):29–36PubMedCrossRefGoogle Scholar
  11. 11.
    Ventura SJ, Abma JC, Mosher WD, Henshaw SK (2008) Estimated pregnancy rates by outcome for the United States, 1990–2004. National Center for Health Statistics. Natl Vital Stat Rep 56(15):1–25PubMedGoogle Scholar
  12. 12.
    Prioux F (2005) Late fertility in Europe: some comparative and historical data. Rev Epidemiol Sante Publique 53(2):2S3–2S11PubMedGoogle Scholar
  13. 13.
    Heck KE, Schoendorf KC, Ventura SJ, Kiely JL (1997) Delayed childbearing by education level in the United States, 1969–1994. Matern Child Health J 1(2):81–88PubMedCrossRefGoogle Scholar
  14. 14.
    Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174–4183PubMedCrossRefGoogle Scholar
  15. 15.
    Ruddy KJ, Gelber S, Ginsburg ES et al (2011) Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause 18(1):105–108PubMedCrossRefGoogle Scholar
  16. 16.
    Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRefGoogle Scholar
  17. 17.
    Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766–773PubMedCrossRefGoogle Scholar
  18. 18.
    Holleb AI (1965) Breast cancer and pregnancy. CA Cancer J Clin 15:182–183PubMedCrossRefGoogle Scholar
  19. 19.
    Azim HA, Peccatori FA, de Azambuja E, Piccart MJ (2011) Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther 11(2):287–298PubMedCrossRefGoogle Scholar
  20. 20.
    de Bree E, Makrigiannakis A, Askoxylakis J (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101(6):534–542PubMedCrossRefGoogle Scholar
  21. 21.
    Azim HA Jr, Santoro S, Pavlidis N et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. EJC 47(1):74–83CrossRefGoogle Scholar
  22. 22.
    Mueller BA, Simon MS, Deapen D et al (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98(6):1131–1140PubMedCrossRefGoogle Scholar
  23. 23.
    Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMedGoogle Scholar
  24. 24.
    Rajkumar L, Guzman RC, Yang J et al (2004) Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 6(1):R31–R37PubMedCrossRefGoogle Scholar
  25. 25.
    Yuri T, Tsukamoto R, Miki K et al (2006) Biphasic effects of zerona on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep 16(6):1307–1312PubMedGoogle Scholar
  26. 26.
    Janerich DT (2001) The fetal antigen hypothesis: cancers and beyond. Med Hypotheses 56(1):101–103PubMedCrossRefGoogle Scholar
  27. 27.
    Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI 98(8):535–544PubMedGoogle Scholar
  28. 28.
    Del Mastro L, Catzeddu T, Venturini M (2006) Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 32(6):417–422PubMedCrossRefGoogle Scholar
  29. 29.
    Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334(7586):194–198PubMedCrossRefGoogle Scholar
  30. 30.
    Partridge AH, Gelber S, Peppercorn J et al (2008) Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 8(1):65–69PubMedCrossRefGoogle Scholar
  31. 31.
    Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24(36):5769–5779PubMedCrossRefGoogle Scholar
  32. 32.
    Faddy MJ, Gosden RG (1995) A mathematical model of follicle dynamics in the human ovary. Hum Reprod 10:770–775PubMedGoogle Scholar
  33. 33.
    Partridge AH, Ruddy KJ (2007) Fertility and adjuvant treatment in young women with breast cancer. Breast 16(S2):S175–S181PubMedCrossRefGoogle Scholar
  34. 34.
    Oktay K, Sönmezer M (2008) Fertility issues and options in young women with cancer. Recent Results Cancer Res 178:203–224PubMedCrossRefGoogle Scholar
  35. 35.
    Jung M, Shin H, Rha S et al (2010) The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up. Ann Surg Oncol 17(12):3259–3268PubMedCrossRefGoogle Scholar
  36. 36.
    Abusief ME, Missmer SA, Ginsburg ES et al (2010) The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 116(4):791–798PubMedCrossRefGoogle Scholar
  37. 37.
    Partridge A, Gelber S, Gelber RD et al (2007) Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from international breast cancer study group trials V and VI. EJC 43:1646–1653CrossRefGoogle Scholar
  38. 38.
    Partridge AH, Ruddy KJ, Gelber S et al (2010) Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 94(2):638–644PubMedCrossRefGoogle Scholar
  39. 39.
    Kroman N, Jensen MB, Melbye M et al (1997) Should women be advised against pregnancy after breast cancer treatment? Lancet 350:319–322PubMedCrossRefGoogle Scholar
  40. 40.
    Velentgas P, Daling JR, Malone KE et al (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424–2432PubMedCrossRefGoogle Scholar
  41. 41.
    Gelber S, Coates AS, Goldhirsch A et al (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675PubMedGoogle Scholar
  42. 42.
    Blakely LJ, Buzdar AU, Lozada JA et al (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100(3):465–469PubMedCrossRefGoogle Scholar
  43. 43.
    Langagergaard V, Gislum M, Skriver MV et al (2006) Birth outcome in women with breast cancer. Br J Cancer 94(1):142–146PubMedCrossRefGoogle Scholar
  44. 44.
    Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer–a population-based cohort study from Sweden. PLoS Med 3(9):e336PubMedCrossRefGoogle Scholar
  45. 45.
    Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRefGoogle Scholar
  46. 46.
    Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K (2010) Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 28(31):4683–4686PubMedCrossRefGoogle Scholar
  47. 47.
    Porcu E, Bazzocchi A, Notarangelo L et al (2008) Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol, Diabetes Obesity 15:529–535CrossRefGoogle Scholar
  48. 48.
    Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G (2010) In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 20(5):634–638PubMedCrossRefGoogle Scholar
  49. 49.
    Oktay K, Buyuk E, Libertella N et al (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353PubMedCrossRefGoogle Scholar
  50. 50.
    West ER, Shea LD, Woodruff TK (2007) Engineering the follicle microenvironment. Semin Reprod Med 25(4):287–299PubMedCrossRefGoogle Scholar
  51. 51.
    Donaldson SS, Link MP, Weinstein HJ et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low risk Hodgkin’s disease. J Clin Oncol 25:332–337PubMedCrossRefGoogle Scholar
  52. 52.
    Blumenfeld Z, Avivi I, Eckman A et al (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166–173PubMedCrossRefGoogle Scholar
  53. 53.
    Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561PubMedCrossRefGoogle Scholar
  54. 54.
    Oktay K, Sonmezer M, Oktem O et al (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12:1055–1066PubMedCrossRefGoogle Scholar
  55. 55.
    Badawy A, Elnashar A, El-Ashry M et al (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 91:694–697PubMedCrossRefGoogle Scholar
  56. 56.
    Gerber B, von Minckwitz G, Stehle H et al (2011) Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 29(17):2334–2341PubMedCrossRefGoogle Scholar
  57. 57.
    Anderson RA, Cameron DA (2011) Pre-treatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 96(5):1336–1343PubMedCrossRefGoogle Scholar
  58. 58.
    Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592–599PubMedCrossRefGoogle Scholar
  59. 59.
    Anderson RA, Themmen APN, Al Qahtani A et al (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reprod 10:2583–2592CrossRefGoogle Scholar
  60. 60.
    Scheffer GJ, Broekmans FJ, Looman CW et al (2003) The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700–706PubMedCrossRefGoogle Scholar
  61. 61.
    Lutchman Singh K, Muttukrishna S, Stein RC et al (2007) Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 96:1808–1816PubMedCrossRefGoogle Scholar
  62. 62.
    Gorman JR, Usita PM, Madlensky L, Pierce JP (2009) A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J Cancer Surviv 3:181–191PubMedCrossRefGoogle Scholar
  63. 63.
    McCullough L, Ng A, Najita J et al (2010) Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer 116(20):4866–4871PubMedCrossRefGoogle Scholar
  64. 64.
    Moran MS, Colasanto JM, Haffty BG et al (2005) Effects of breast-conserving therapy on lactation after pregnancy. Cancer 11:399–403CrossRefGoogle Scholar
  65. 65.
    Azim HA Jr, Bellettini G, Gelber S, Peccatori FA (2009) Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res Treat 114(1):7–12PubMedCrossRefGoogle Scholar
  66. 66.
    Azim HA Jr, Bellettini G, Liptrott SJ et al (2010) Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast 19(6):527–531PubMedCrossRefGoogle Scholar
  67. 67.
    Helewa M, Levesque P, Provencher D et al (2002) Breast Disease Committee and Executive Committee and Council, Society of Obstetricians and Gynaecologists of Canada. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24(2):164–180PubMedGoogle Scholar
  68. 68.
    Camune B, Gabzdyl E (2007) Breast-feeding after breast cancer in childbearing women. J Perinat Neonat Nurs 21(3):225–233Google Scholar
  69. 69.
    Rosenberg R, Levy-Schwartz R (2003) Breast cancer in women younger than 40 years. Int J Fertil 48(5):200–205Google Scholar
  70. 70.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717CrossRefGoogle Scholar
  71. 71.
    Cuzick J, Ambroisine L, Davidson N et al (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369:1711–1723PubMedCrossRefGoogle Scholar
  72. 72.
    International Breast Cancer Study Group (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group trial 13–93. J Clin Oncol 24:1332–1341CrossRefGoogle Scholar
  73. 73.
    Swain SM, Jeong JH, Geyer CE Jr et al (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053–2065PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Olivia Pagani
    • 1
  • Ann Partridge
    • 2
  • Larissa Korde
    • 3
  • Sunil Badve
    • 4
  • John Bartlett
    • 5
  • Kathy Albain
    • 6
  • Richard Gelber
    • 7
  • Aron Goldhirsch
    • 8
    • 9
  1. 1.Institute of Oncology of Southern Switzerland (IOSI) and International Breast Cancer Study Group (IBCSG)ViganelloSwitzerland
  2. 2.Dana-Farber Cancer InstituteBostonUSA
  3. 3.Division of Medical OncologyUniversity of WashingtonSeattleUSA
  4. 4.Pathology and Lab MedicineIndiana UniversityIndianapolisUSA
  5. 5.Endocrine Cancer Group, Edinburgh Cancer Research CentreEdinburghUK
  6. 6.Chicago Stritch School of MedicineLoyola UniversityMaywoodUSA
  7. 7.IBCSG Statistical Center, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard School of Public Health and Harvard Medical SchoolBostonUSA
  8. 8.Swiss Center for Breast HealthLuganoSwitzerland
  9. 9.European Institute of OncologyMilanItaly

Personalised recommendations